| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |